II. Definitions
III. Epidemiology
-
Incidence in United States
- Ages 20 to 39 years: 7.5%
- Ages 40 to 49 years: 11%
- Ages 50 to 59 years: 18%
- Ages 60 to 69 years: 38%
- Age over 70 years: 57%
- Prevalence in United States: 10-20 Million
IV. Pathophysiology
- See Penile Anatomy and Erection physiology
- Organic disease responsible for 80% of cases
- Arterial or venous disease accounts for 70% of cases
V. Causes
VI. History
- Assess Severity of symptoms
- Characteristics of Erectile Dysfunction
- Frequency and duration of Impotence
- Partial or complete lack of rigidity (and absent of morning Erection)
- Vascular causes (e.g. Peripheral Vascular Disease)
- Medication causes of Erectile Dysfunction
- Pelvic surgery
- Libido difficulties
- Hypogonadism
- Hpothyroidism
- Maor depression
- No orgasm (anorgasmia) or decreased quality of orgasm
- Alcohol Abuse
- Thyroid disease
- Medication causes of Erectile Dysfunction
- Major Depression
- Pelvic surgery or irradiation
- Decreased ejaculate volume
- Normal aging
- Chronic Prostatitis
- Ejaculatory duct obstruction
- Retrograde ejaculation
- Painful sexual intercourse
- Sexual abuse
- Genital Piercings
- Sexually Transmitted Disease (e.g. Herpes Simplex Virus Infection)
- Symptoms suggestive of Psychogenic Impotence
- Review potential Impotence Causes
- Consider comorbid conditions
- Coronary Artery Disease is common in Impotence
VII. Exam
-
Blood Pressure
- Cardiovascular disease
- Peripheral Vascular Disease
-
Heart Rate
- Generalized Anxiety Disorder
- Hyperthyroidism
- Stimulant Disease
- Cardiovascular Disease
- Body Mass Index (BMI)
- Auscultate Great Vessels for Arterial Bruits
- Penile curvature
- Peyronie Disease
- Ruptured corpora cavernosum
- Venous leakage
- Endocrine exam
- Thyroid Exam
- Hypogonadism Signs
- Testicular atrophy
- Gynecomastia
- Neurologic function (Rectal Tone, Bulbocavernosus Reflex, perineal Sensation)
- Lumbar central spinal stenosis
- Pelvic surgery
- Pelvic Trauma
- Prostate enlargement
VIII. Evaluation: Scales
- Depression Screening (e.g. PHQ-9)
- International Index of Erectile Function Questionnaire (IIEF-5)
IX. Labs: Initial
- Fasting Serum Glucose (or Hemoglobin A1C)
- Fasting Lipid profile
- Morning Total Testosterone Level
- Indications: Hyogonadism signs (controversial)
- Small Testes
- Lack of male secondary sex characteristics
- Very low libido
- Inadequate PDE-5 Inhibitor (e.g. Viagra) response
- Indicated in most cases (especially men over age 50 years, and in signs of Hypogonadism)
- Interpretation
- Total Testosterone <300 ng/ml suggests Hypogonadism
- Confirm abnormal Serum Testosterone with repeat test in 2-3 months
- Consider free Testosterone Level if repeatedly normal, however levels are not standardized
- Consider Testosterone Supplementation for persistently low Testosterone
- Indications: Hyogonadism signs (controversial)
-
Thyroid Stimulating Hormone (TSH)
- Especially indicated in all older men
X. Labs: Endocrine as indicated
- Follicle Stimulating Hormone (FSH)
-
Luteinizing Hormone (LH) Indications
- Hypogonadism evaluation for low Testosterone
-
Prolactin Level Indications
- Suspected Prolactinoma
- Serum Free Testosterone decreased
- Libido decreased significantly
XI. Labs: Other tests if indicated
- Serum Chemistry Panel (Chem7)
- Urinalysis
- Complete Blood Count
- Prostate Specific Antigen (PSA)
XII. Evaluation: Assessment of nighttime Erection
- Indication: Psychogenic cause suspected
- Rarely performed now
- Techniques
- Snap-gauge cuff
- Rigiscan (Nocturnal penile tumescence monitoring)
XIII. Evaluation: Advanced Testing by Urology
- Biothesiometry
- Penile-brachial index
- Duplex Ultrasound (Color flow doppler)
- Cavernosometry or Cavernosography
- Arteriography
- Psychological Testing
XIV. Management
XV. Precautions: Cardiovascular Risk
- Erectile Dysfunction is a Cardiovascular Risk
- Mortality Hazard Ratio: 2.04
- Cardiovascular event Hazard Ratio: 1.62
- More severe Erectile Dysfunction is associated with higher Cardiovascular Risk
- Bohm (2010) Circulation 121:1375-1376 [PubMed]
- Erectile Dysfunction may be comorbid with cardiovascular disease
- Consider Cardiovascular Risk management
XVI. References
- Beaudreau (August, 2000) Federal Practitioner, p. 11-8
- Ferris (1997) Fam Pract Recert 19(1):47-58
- Napolatono (1998) Fam Pract Recert 20(11): 34-58
- Dewire (1996) Am Fam Physician 53(6): 2101-6 [PubMed]
- Greiner (1996) Am Fam Physician 54(5): 1675-82 [PubMed]
- Guay (1995) Postgrad Med 97(4): 127-43 [PubMed]
- Jordan (1999) Postgrad Med 105(2): 131-47 [PubMed]
- Viera (1999) Am Fam Physician 60(4): 1159-66 [PubMed]
- Heidelbaugh (2010) Am Fam Physician 81(3): 305-12 [PubMed]
- McVary (2007) N Engl J Med 357(24): 2472-81 [PubMed]
- Rew (2016) Am Fam Physician 94(10): 820-7 [PubMed]